302 Appendices 308. Thunnissen E, Motoi N, Minami Y, et al. Elastin in pulmonary pathology: relevance in tumors with lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint. Histopathology. Published online August 2021. doi:10.1111/his.14537 309. Borczuk AC. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma. Mod Pathol. 2012;25 Suppl 1(S1):S1-S10. doi:10.1038/modpathol.2011.151 310. Yim J, Zhu L-C, Chiriboga L, Watson HN, Goldberg JD, Moreira AL. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol. 2007;20(2):233-241. doi:10.1038/modpathol.3800734 311. Shih A. Problems in the Reproducibility of Classification of Small Lung Adenocarcinoma: An International Interobserver Study. Histopathology. Published online 2019. 312. Boland JM, Froemming AT, Wampfler JA, et al. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma - Analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules. Hum Pathol. 2016;51:41-50. doi:10.1016/j.humpath.2015.12.010 313. Nicholson AG, Tsao MS, Travis WD, et al. Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist. Arch Pathol Lab Med. 2018;142(5):645-661. doi:10.5858/arpa.2017-0245-RA 314. Travis WD. Invasive non-mucinous adenocarcinoma of the lung. In: WHO Classification of Tumours Editorial Board. Thoracic Tumours [Internet]. Lyon (France): International Agency for Research on Cancer. ; 2021. 315. Yotsukura M, Asamura H, Motoi N, et al. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung. J Thorac Oncol. 2021;16(8):1312-1320. doi:10.1016/j.jtho.2021.04.007 316. Kadota K, MacMahon H, Matsubara D, Mino-Kenudson M MT. Adenocarcinoma in situ. In: WHO Classification of Tumours Editorial Board. Thoracic Tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2021. (WHO Classification of Tumours Series, 5th Ed.; Vol. 5). Available from: Https://Tumourclassification.Iarc.Who.In. ; 2021. 317. Thunnissen E, Beasley MB, Borczuk A, et al. Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee. J Thorac Oncol. Published online December 2022. doi:10.1016/j. jtho.2022.11.026 318. Nagaiushi C. Bronchoalveolar System. In: Nagaiushi C, ed. Functional Anatomy and Histology of the Lung. 1st ed. ; 1972:1-65. 319. Min Kung IT, Lin Lui IO, Loke SL, et al. Pulmonary scar cancer. A pathologic reappraisal. Am J Surg Pathol. 1985;9(6):391-400. doi:10.1097/00000478-198506000-00001 320. Blaauwgeers H, Radonic T, Lissenberg-Witte B, et al. P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study. J Thorac Oncol. 2021;16(10):S985. doi:10.1016/j.jtho.2021.08.281 321. Weibel ER. Stereological Methods for Biological Morphometry: 001. 1st ed. Academic Press Inc.; 1979. 322. Nakazato Y, Minami Y, Kobayashi H, et al. Nuclear grading of primary pulmonary adenocarcinomas: Correlation between nuclear size and prognosis. Cancer. 2010;116(8):20112019. doi:10.1002/cncr.24948 323. Goto K, Yokose T, Kodama T, et al. Detection of early invasion on the basis of basement membrane destruction in small adenocarcinomas of the lung and its clinical Implications. Mod Pathol. 2001;14(12):1237-1245. doi:10.1038/modpathol.3880468 324. Mackinnon AC, Luevano A, De Araujo LC, Rao N, Le M, Suster S. Cribriform adenocarcinoma of the lung: Clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mod Pathol. 2014;27(8):10631072. doi:10.1038/modpathol.2013.227
RkJQdWJsaXNoZXIy MTk4NDMw